Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

BACKGROUND: Hepatic artery infusion chemotherapy (HAIC) and anti-programmed cell death protein-1 (PD-1) immunotherapy have shown promising outcomes in patients with advanced hepatocellular carcinoma (HCC), respectively. However, the combination of the two treatments has not been reported. In this st...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Hepatocell Carcinoma
Hlavní autoři: Mei, Jie, Li, Shao-Hua, Li, Qi-Jiong, Sun, Xu-Qi, Lu, Liang-He, Lin, Wen-Ping, Zheng, Lie, Chen, Min-Shan, Shi, Ming, Wei, Wei, Guo, Rong-Ping
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2021
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8007560/
https://ncbi.nlm.nih.gov/pubmed/33791252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S298538
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky